c-Abl tyrosine kinase regulates cardiac growth and development

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 3, 2010, Pages 1136-1141

  Qiua, Zhaozhu ^a   Cang, Yong ^a,b   Goff, Stephen P ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Abelson; Heart development; Hyperproliferation

Indexed keywords

ABELSON KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE MUTATION; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; CELL PROLIFERATION; GENES, LETHAL; HEART; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-ABL;

MAMMALIA;

EID: 75749113347     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0913131107     Document Type: Article

References (32)

1. Sedmera D, Pexieder T, Vuillemin M, Thompson RP, Anderson RH (2000) Developmental patterning of the myocardium. Anat Rec 258:319-337.
2. Srivastava D (2006) Making or breaking the heart: from lineage determination to morphogenesis. Cell 126:1037-1048.
3. Olson EN (2006) Gene regulatory networks in the evolution and development of the heart. Science 313:1922-1927.
4. Pasumarthi KB, Field LJ (2002) Cardiomyocyte cell cycle regulation. Circ Res 90: 1044-1054.
5. Ahuja P, Sdek P, MacLellan WR (2007) Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 87:521-544.
6. Pendergast AM (2002) The Abl family kinases: mechanisms of regulation and signaling. Adv Cancer Res 85:51-100.
7. Li B, et al. (2000) Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat Genet 24:304-308.
8. Schwartzberg PL, et al. (1991) Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65:1165-1175.
9. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC (1991) Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl protooncogene. Cell 65:1153-1163.
10. Toyofuku T, et al. (2004) Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat Cell Biol 6:1204-1211.
11. Kerkela R, et al. (2006) Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 12:908-916.
12. Pye SM, et al. (2008) The effects of imatinib on pregnancy outcome. Blood 111: 5505-5508.
13. Swynghedauw B (1999) Molecular mechanisms of myocardial remodeling. Physiol Rev 79:215-262.
14. Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H (2007) Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev 12:331-343.
15. Zhu J, Wang JY (2004) Death by Abl: a matter of location. Curr Top Dev Biol 59: 165-192.
16. Wen ST, Jackson PK, Van Etten RA (1996) The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J 15:1583-1595.
17. Agah R, et al. (1997) Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100:169-179.
18. Henson M, et al. (2000) Insulin-like growth factor-binding protein-3 induces fetalization in neonatal rat cardiomyocytes. DNA Cell Biol 19:757-763.
19. Mikhailov AT, Torrado M (2008) The enigmatic role of the ankyrin repeat domain 1 gene in heart development and disease. Int J Dev Biol 52:811-821.
20. Shi-Wen X, Leask A, Abraham D (2008) Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 19:133-144.
21. Gertler FB, Bennett RL, Clark MJ, Hoffmann FM (1989) Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 58:103-113.
22. Gertler FB, Doctor JS, Hoffmann FM (1990) Genetic suppression of mutations in the Drosophila abl proto-oncogene homolog. Science 248:857-860.
23. Goga A, et al. (1995) p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 11:791-799.
24. Sawyers CL, McLaughlin J, Goga A, Havlik M, Witte O (1994) The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77:121-131.
25. Lin J, Arlinghaus R (2008) Activated c-Abl tyrosine kinase in malignant solid tumors. Oncogene 27:4385-4391.
26. Plattner R, Kadlec L, DeMali KA, Kazlauskas A, Pendergast AM (1999) c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev 13:2400-2411.
27. Gu JJ, Ryu JR, Pendergast AM (2009) Abl tyrosine kinases in T-cell signaling. Immunol Rev 228:170-183.
28. Kozar K, et al. (2004) Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477-491.
29. Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ (2005) Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 96:110-118.
30. Soonpaa MH, et al. (1997) Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest 99:2644-2654.
31. Noren NK, Foos G, Hauser CA, Pasquale EB (2006) The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol 8: 815-825.
32. Gerety SS, Wang HU, Chen ZF, Anderson DJ (1999) Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell 4:403-414.